| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 23, 2003
Accepted on June 9, 2003
1 Laboratory of Genetics, CNRS, UMR5641, Faculty of Medicine University of Lyon 1, 8 Avenue Rockefeller, 69373 Lyon, France; International Agency for Research on Cancer (IARC), 150 cours Albert-Thomas, 69008 Lyon, France
* To whom correspondence should be addressed. E-mail: zqwang{at}iarc.fr.
Multiple endocrine neoplasia type 1 (MEN1) is a hereditary syndrome characterized by the occurrence of multiple endocrine tumors of the parathyroid, pancreas and anterior pituitary in patients. To study tumorigenesis related to the MEN1 syndrome, we have generated Men1 knockout mice using the gene targeting approach. Heterozygous Men1 mutant mice developed the same range of major endocrine tumors as is seen in MEN1 patients, affecting the parathyroid, pancreatic islets, pituitary and adrenal glands, as well as the thyroid, and exhibiting multistage tumor progression with metastatic potential. In particular, extra-pancreatic gastrinoma, pancreatic glucagonoma, and mixed hormone-producingtumors in islets were observed. In addition, there was a high incidence of gonadal tumors of endocrine origin, i.e. Leydig cell tumors, and ovary sex-cord stromal cell tumors in heterozygous Men1 mutant mice. Hormonal disturbance, such as abnormal PTH and insulin levels, was also observed in these mice. These tumors were associated with loss of heterozygosity of the wild-type Men1 allele, suggesting that menin is involved in suppressing the development of these endocrine tumors. All these features are reminiscent of MEN1 symptoms in humans and establish heterozygous Men1 mutant mice as a suitable model for this disease.
This article has been cited by other articles:
![]() |
S. Fontaniere, B. Duvillie, R. Scharfmann, C. Carreira, Z.-Q. Wang, and C.-X. Zhang Tumour suppressor menin is essential for development of the pancreatic endocrine cells J. Endocrinol., November 1, 2008; 199(2): 287 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hussein, J. Lu, H. Casse, S. Fontaniere, A.-M. Morera, S. M. Guittot, A. Calender, N. Di Clemente, and C. X Zhang Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice Endocr. Relat. Cancer, March 1, 2008; 15(1): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H-C J. Shen, J. E Rosen, L. M Yang, S. A Savage, A L. Burns, C. M Mateo, S. K Agarwal, S. C Chandrasekharappa, A. M Spiegel, F. S Collins, et al. Parathyroid tumor development involves deregulation of homeobox genes Endocr. Relat. Cancer, March 1, 2008; 15(1): 267 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matoso, Z. Zhou, R. Hayama, A. Flesken-Nikitin, and A. Yu. Nikitin Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia Carcinogenesis, March 1, 2008; 29(3): 620 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. La, Y. Yang, S. K. Karnik, A. C. Silva, R. W. Schnepp, S. K. Kim, and X. Hua Menin-mediated Caspase 8 Expression in Suppressing Multiple Endocrine Neoplasia Type 1 J. Biol. Chem., October 26, 2007; 282(43): 31332 - 31340. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji, N. B. Prasad, E. A. Novotny, S. Kaur, A. Elkahloun, Y. Chen, R.-Z. Zhang, M.-L. Chu, S. K. Agarwal, S. J. Marx, et al. Mouse Embryo Fibroblasts Lacking the Tumor Suppressor Menin Show Altered Expression of Extracellular Matrix Protein Genes Mol. Cancer Res., October 1, 2007; 5(10): 1041 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Pei, F. Bai, M. D. Smith, and Y. Xiong p18Ink4c Collaborates with Men1 to Constrain Lung Stem Cell Expansion and Suppress Non-Small-Cell Lung Cancers Cancer Res., April 1, 2007; 67(7): 3162 - 3170. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bai, X.-H. Pei, T. Nishikawa, M. D. Smith, and Y. Xiong p18Ink4c, but Not p27Kip1, Collaborates with Men1 To Suppress Neuroendocrine Organ Tumors Mol. Cell. Biol., February 15, 2007; 27(4): 1495 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Fontaniere, J Tost, A Wierinckx, J Lachuer, J Lu, N Hussein, F Busato, I Gut, Z-Q Wang, and C-X Zhang Gene expression profiling in insulinomas of Men1 {beta}-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic {beta}-cell tumorigenesis Endocr. Relat. Cancer, December 1, 2006; 13(4): 1223 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. MacConaill, C. M. Hughes, O. Rozenblatt-Rosen, S. Nannepaga, and M. Meyerson Phosphorylation of the Menin Tumor Suppressor Protein on Serine 543 and Serine 583 Mol. Cancer Res., October 1, 2006; 4(10): 793 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Schnepp, Y.-X. Chen, H. Wang, T. Cash, A. Silva, J. A. Diehl, E. Brown, and X. Hua Mutation of Tumor Suppressor Gene Men1 Acutely Enhances Proliferation of Pancreatic Islet Cells Cancer Res., June 1, 2006; 66(11): 5707 - 5715. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Roccabianca, M. Rondena, S. Paltrinieri, V. Pocacqua, P. Scarpa, S. Faverzani, E. Scanziani, and M. Caniatti Multiple Endocrine Neoplasia Type-I-like Syndrome in Two Cats Vet. Pathol., May 1, 2006; 43(3): 345 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matsumoto, A. Kubo, H. Liu, K. Akita, F. Laub, F. Ramirez, G. Keller, and S. L. Friedman Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6 Blood, February 15, 2006; 107(4): 1357 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Corbetta, L Vicentini, S Ferrero, A Lania, G Mantovani, D Cordella, P Beck-Peccoz, and A Spada Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors Endocr. Relat. Cancer, December 1, 2005; 12(4): 929 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Karnik, C. M. Hughes, X. Gu, O. Rozenblatt-Rosen, G. W. McLean, Y. Xiong, M. Meyerson, and S. K. Kim Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c PNAS, October 11, 2005; 102(41): 14659 - 14664. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Scacheri, A. L. Kennedy, K. Chin, M. T. Miller, J. G. Hodgson, J. W. Gray, S. J. Marx, A. M. Spiegel, and F. S. Collins Pancreatic Insulinomas in Multiple Endocrine Neoplasia, Type I Knockout Mice Can Develop in the Absence of Chromosome Instability or Microsatellite Instability Cancer Res., October 1, 2004; 64(19): 7039 - 7044. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sowa, H. Kaji, G. N. Hendy, L. Canaff, T. Komori, T. Sugimoto, and K. Chihara Menin Is Required for Bone Morphogenetic Protein 2- and Transforming Growth Factor {beta}-regulated Osteoblastic Differentiation through Interaction with Smads and Runx2 J. Biol. Chem., September 24, 2004; 279(39): 40267 - 40275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Schnepp, Z. Hou, H. Wang, C. Petersen, A. Silva, H. Masai, and X. Hua Functional Interaction between Tumor Suppressor Menin and Activator of S-Phase Kinase Cancer Res., September 15, 2004; 64(18): 6791 - 6796. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ratineau, C. Bernard, G. Poncet, M. Blanc, C. Josso, S. Fontaniere, A. Calender, J. A. Chayvialle, C.-X. Zhang, and C. Roche Reduction of Menin Expression Enhances Cell Proliferation and Is Tumorigenic in Intestinal Epithelial Cells J. Biol. Chem., June 4, 2004; 279(23): 24477 - 24484. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stalberg, P. Grimfjard, M. Santesson, Y. Zhou, D. Lindberg, A. Gobl, K. Oberg, G. Westin, J. Rastad, S. Wang, et al. Transfection of the Multiple Endocrine Neoplasia Type 1 Gene to a Human Endocrine Pancreatic Tumor Cell Line Inhibits Cell Growth and Affects Expression of JunD, {delta}-Like Protein 1/Preadipocyte Factor-1, Proliferating Cell Nuclear Antigen, and QM/Jif-1 J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2326 - 2337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Biondi, M. G. Gartside, P. Waring, K. A. Loffler, M. S. Stark, M. A. Magnuson, G. F. Kay, and N. K. Hayward Conditional Inactivation of the Men1 Gene Leads to Pancreatic and Pituitary Tumorigenesis but Does Not Affect Normal Development of These Tissues Mol. Cell. Biol., April 15, 2004; 24(8): 3125 - 3131. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sowa, H. Kaji, R. Kitazawa, S. Kitazawa, T. Tsukamoto, S. Yano, T. Tsukada, L. Canaff, G. N. Hendy, T. Sugimoto, et al. Menin Inactivation Leads to Loss of Transforming Growth Factor {beta} Inhibition of Parathyroid Cell Proliferation and Parathyroid Hormone Secretion Cancer Res., March 15, 2004; 64(6): 2222 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Libutti, J. S. Crabtree, D. Lorang, A. L. Burns, C. Mazzanti, S. M. Hewitt, S. O'Connor, J. M. Ward, M. R. Emmert-Buck, A. Remaley, et al. Parathyroid Gland-specific Deletion of the Mouse Men1 Gene Results in Parathyroid Neoplasia and Hypercalcemic Hyperparathyroidism Cancer Res., November 15, 2003; 63(22): 8022 - 8028. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |